Home LiteratureArticle Details
PMID: 2513570 Published · ppublish English Journal Article

A humanized antibody that binds to the interleukin 2 receptor.

Queen C, Schneider WP, Selick HE, Payne PW, Landolfi NF, Duncan JF, Avdalovic NM, Levitt M, Junghans RP, Waldmann TA

Abstract

The anti-Tac monoclonal antibody is known to bind to the p55 chain of the human interleukin 2 receptor and to inhibit proliferation of T cells by blocking interleukin 2 binding. However, use of anti-Tac as an immunosuppressant drug would be impaired by the human immune response against this murine antibody. We have therefore constructed a "humanized" antibody by combining the complementarity-determining regions (CDRs) of the anti-Tac antibody with human framework and constant regions. The human framework regions were chosen to maximize homology with the anti-Tac antibody sequence. In addition, a computer model of murine anti-Tac was used to identify several amino acids which, while outside the CDRs, are likely to interact with the CDRs or antigen. These mouse amino acids were also retained in the humanized antibody. The humanized anti-Tac antibody has an affinity for p55 of 3 x 10(9) M-1, about 1/3 that of murine anti-Tac.

MeSH Terms
Amino Acid Sequence Animals Antibodies, Monoclonal/genetics,immunology Antigen-Antibody Complex Base Sequence Chimera Cloning, Molecular Computer Simulation Exons Genes, Immunoglobulin Humans Immunoglobulin Constant Regions/genetics Immunoglobulin Heavy Chains/genetics Immunoglobulin Light Chains/genetics Immunoglobulin Variable Region/genetics Mice Models, Molecular Molecular Sequence Data Oligonucleotide Probes Plasmids Protein Conformation Receptors, Interleukin-2/immunology Sequence Homology, Nucleic Acid Software
Chemicals
Antibodies, Monoclonal Antigen-Antibody Complex Immunoglobulin Constant Regions Immunoglobulin Heavy Chains Immunoglobulin Light Chains Immunoglobulin Variable Region Oligonucleotide Probes Receptors, Interleukin-2
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Queen C
Protein Design Labs, Palo Alto, CA 94304.
Schneider W P
Selick H E
Payne P W
Landolfi N F
Duncan J F
Avdalovic N M
Levitt M
Junghans R P
Waldmann T A
References (33)
33 references, click to expand
  1. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  2. Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments.
    Cell. 1980 Nov;22(1 Pt 1):197-207 PMID: 6775818
  3. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.
    J Immunol. 1981 Apr;126(4):1393-7 PMID: 6970774
  4. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.
    Proc Natl Acad Sci U S A. 1981 Apr;78(4):2072-6 PMID: 7017722
  5. The nucleotide sequence of a human immunoglobulin C gamma1 gene.
    Nucleic Acids Res. 1982 Jul 10;10(13):4071-9 PMID: 6287432
  6. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.
    Nature. 1982 Nov 18;300(5889):267-9 PMID: 6815536
  7. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
    J Immunol. 1983 Aug;131(2):690-6 PMID: 6408186
  8. Molecular dynamics of native protein. I. Computer simulation of trajectories.
    J Mol Biol. 1983 Aug 15;168(3):595-617 PMID: 6193280
  9. A simple and very efficient method for generating cDNA libraries.
    Gene. 1983 Nov;25(2-3):263-9 PMID: 6198242
  10. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
    Proc Natl Acad Sci U S A. 1984 Nov;81(21):6851-5 PMID: 6436822
  11. Production of functional chimaeric mouse/human antibody.
    Nature. 1984 Dec 13-19;312(5995):643-6 PMID: 6095115
  12. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.
    Mol Cell Biol. 1985 Feb;5(2):410-3 PMID: 2983194
  13. A hapten-specific chimaeric IgE antibody with human physiological effector function.
    Nature. 1985 Mar 21-27;314(6008):268-70 PMID: 2580239
  14. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
    Gene. 1985;33(1):103-19 PMID: 2985470
  15. Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.
    J Exp Med. 1985 Jul 1;162(1):358-62 PMID: 3925068
  16. Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.
    Proc Natl Acad Sci U S A. 1986 Apr;83(8):2624-7 PMID: 2939456
  17. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
    Transplantation. 1986 May;41(5):572-8 PMID: 3085297
  18. Replacing the complementarity-determining regions in a human antibody with those from a mouse.
    Nature. 1986 May 29-Jun 4;321(6069):522-5 PMID: 3713831
  19. Synergism between immunoglobulin enhancers and promoters.
    Nature. 1986 Jul 24-30;322(6077):383-5 PMID: 3016550
  20. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions.
    Science. 1986 Nov 14;234(4778):859-63 PMID: 3095922
  21. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9694-8 PMID: 3099289
  22. Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.
    Proc Natl Acad Sci U S A. 1987 Jan;84(1):214-8 PMID: 3025856
  23. Effects of in-vivo administration of a monoclonal antibody specific for the interleukin-2 receptor on the acute graft-versus-host reaction in mice.
    Clin Exp Immunol. 1986 Oct;66(1):126-31 PMID: 3100116
  24. Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3439-43 PMID: 3106970
  25. Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.
    J Immunol. 1988 Jan 1;140(1):59-61 PMID: 3121742
  26. Reshaping human antibodies for therapy.
    Nature. 1988 Mar 24;332(6162):323-7 PMID: 3127726
  27. Reshaping human antibodies: grafting an antilysozyme activity.
    Science. 1988 Mar 25;239(4847):1534-6 PMID: 2451287
  28. Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2.
    Blood. 1988 Nov;72(5):1805-16 PMID: 2846094
  29. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
    Lancet. 1988 Dec 17;2(8625):1394-9 PMID: 2904526
  30. Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.
    Transplantation. 1989 Jan;47(1):55-9 PMID: 2643232
  31. Expression in COS cells of a mouse-human chimaeric B72.3 antibody.
    Protein Eng. 1987 Dec;1(6):499-505 PMID: 3508296
  32. Early experience with anti-Tac in clinical renal transplantation.
    Transplant Proc. 1989 Feb;21(1 Pt 2):1766-8 PMID: 2652578
  33. The multi-subunit interleukin-2 receptor.
    Annu Rev Biochem. 1989;58:875-911 PMID: 2673025
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1989-12-00
Pages
10029-33
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC298637
Subset
IM
Databases
GENBANK
M28250, M28251
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com